Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 1, 2017
- Revision received October 2, 2017
- Accepted October 17, 2017
- Published first October 20, 2017.
Article Versions
- Previous version (October 20, 2017 - 05:51).
- You are currently viewing a Previous version of this article (December 20, 2017 - 07:51).
- View the most recent version of this article
Copyright & Usage
©2017 American Association for Cancer Research.
Author Information
- Maria Rusan1,2,3,
- Kapsok Li1,4,
- Yvonne Li1,3,
- Camilla L. Christensen1,
- Brian J. Abraham5,
- Nicholas Kwiatkowski5,6,7,
- Kevin A. Buczkowski1,
- Bruno Bockorny1,3,8,
- Ting Chen1,
- Shuai Li1,
- Kevin Rhee1,
- Haikuo Zhang1,
- Wankun Chen1,9,10,
- Hideki Terai1,
- Tiffany Tavares1,
- Alan L. Leggett6,
- Tianxia Li1,
- Yichen Wang1,
- Tinghu Zhang6,7,
- Tae-Jung Kim1,11,
- Sook-Hee Hong1,
- Neermala Poudel-Neupane1,
- Michael Silkes1,
- Tenny Mudianto1,
- Li Tan6,7,
- Takeshi Shimamura12,
- Matthew Meyerson1,3,
- Adam J. Bass1,3,13,
- Hideo Watanabe14,
- Nathanael S. Gray6,7,
- Richard A. Young5,15,
- Kwok-Kin Wong16 and
- Peter S. Hammerman1,3,17,*
- 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
- 2Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- 3Cancer Program, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts.
- 4Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Korea.
- 5Whitehead Institute for Biomedical Research, Cambridge, Massachusetts.
- 6Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
- 7Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts.
- 8Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
- 9Department of Anesthesiology, Fudan University Shanghai Cancer Center, Shanghai, China.
- 10Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
- 11Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- 12Molecular Pharmacology and Therapeutics, Oncology Research Institute, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois.
- 13Departments of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, Massachusetts.
- 14Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine and Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
- 15Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts.
- 16Laura & Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York.
- 17Novartis Institutes of Biomedical Research, Cambridge, Massachusetts.
- ↵*Corresponding Author:
Peter S. Hammerman, Novartis Institutes of Biomedical Research, Cambridge, MA 02139. Phone: 617-632-6335; Fax: 617-582-7880; E-mail: peter.hammerman{at}novartis.com
Published OnlineFirst December 20, 2017
doi: 10.1158/2159-8290.CD-17-0461
Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression
Jump to section
Advertisement